Published on 4/13/2016 in the Prospect News Structured Products Daily.
New Issue: UBS prices $379,624 4.97% trigger yield optimization notes linked to Gilead
New York, April 13 – UBS AG, London Branch priced $379,624.14 of 4.97% trigger yield optimization notes due April 19, 2017 linked to the common stock of Gilead Sciences, Inc., according to a 424B2 filing with the Securities and Exchange Commission.
The face amount of each note is $97.19, which is equal to the initial share price of Gilead Sciences stock.
Interest is payable monthly.
The payout at maturity will be par unless the final price of Gilead Sciences stock is less than 78% of the initial share price, in which case investors will receive one Gilead Sciences share per note.
UBS Financial Services Inc. and UBS Investment Bank are the underwriters.
Issuer: | UBS AG, London Branch
|
Issue: | Trigger yield optimization notes
|
Underlying stock: | Gilead Sciences, Inc. (Nasdaq: GILD)
|
Amount: | $379,624.14
|
Maturity: | April 19, 2017
|
Coupon: | 4.97%, payable monthly
|
Price: | Par of $97.19
|
Payout at maturity: | If final share price is less than trigger price, one Gilead Sciences share; otherwise, par
|
Initial share price: | $97.19
|
Trigger price: | $75.81, 78% of initial price
|
Pricing date: | April 13
|
Settlement date: | April 18
|
Underwriters: | UBS Financial Services Inc. and UBS Investment Bank
|
Fees: | 2%
|
Cusip: | 90275V175
|
|
|
© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere.
For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.